{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:31:21Z","timestamp":1773693081493,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen-Ortho"},{"name":"Eli Lily"},{"DOI":"10.13039\/100005632","name":"Forest","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shire"},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009654","name":"Sepracor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009654","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Otsuka"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jpsychires.2020.03.020","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T02:33:35Z","timestamp":1586399615000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Registered clinical trials investigating ketamine for psychiatric disorders"],"prefix":"10.1016","volume":"127","author":[{"given":"Bahareh","family":"Peyrovian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanna M.W.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartej","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chen-Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Nasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jpsychires.2020.03.020_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2217\/fon-2017-0722","article-title":"The next generation of therapy for multiple myeloma: a review of ongoing clinical trials utilizing ClinicalTrials.gov","volume":"14","author":"Barth","year":"2018","journal-title":"Future Oncol."},{"issue":"4","key":"10.1016\/j.jpsychires.2020.03.020_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2020.03.020_bib3","doi-asserted-by":"crossref","DOI":"10.2217\/imt-2018-0019","article-title":"Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy","volume":"10","author":"Cushman","year":"2018","journal-title":"Immunotherapy"},{"issue":"11","key":"10.1016\/j.jpsychires.2020.03.020_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: a randomized clinical trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"Am. J. Psychiatr."},{"issue":"9","key":"10.1016\/j.jpsychires.2020.03.020_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2020.03.020_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatr."},{"issue":"7661","key":"10.1016\/j.jpsychires.2020.03.020_bib7","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0140-6736(70)91273-0","article-title":"Ketamine as an induction agent IN an\u00e6sthetics","volume":"295","author":"Dundee","year":"1970","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jpsychires.2020.03.020_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2020.03.020_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2020.03.020_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","author":"Hashimoto","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jpsychires.2020.03.020_bib11","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2020.03.020_bib12","doi-asserted-by":"crossref","first-page":"m329","DOI":"10.1136\/bmj.m329","article-title":"Esketamine for treatment resistant depression is not recommended by NICE","volume":"368","author":"Mahase","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jpsychires.2020.03.020_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jpsychires.2020.03.020_bib14","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"October). Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.03.020_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","author":"Peltoniemi","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.jpsychires.2020.03.020_bib16","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2020.03.020_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112508","article-title":"Ketamine: the final frontier or another depressing end?","author":"Sial","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2020.03.020_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/npp.2017.194","article-title":"Ketamine for social anxiety disorder: a randomized, placebo-controlled crossover trial","volume":"43","author":"Taylor","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2020.03.020_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(19)30394-3","article-title":"Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval","author":"Turner","year":"2019","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.03.020_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172870","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","author":"Wei","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.jpsychires.2020.03.020_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.03.020_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cobeha.2018.02.001","article-title":"Sex differences in sub-anesthetic ketamine's antidepressant effects and abuse liability","author":"Wright","year":"2018","journal-title":"Curr. Opin. Behav. Sci."},{"issue":"7604","key":"10.1016\/j.jpsychires.2020.03.020_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jpsychires.2020.03.020_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"issue":"11","key":"10.1016\/j.jpsychires.2020.03.020_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2020.03.020_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.03.020_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2020.05.154","article-title":"March 15). Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies","author":"Zheng","year":"2020","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620300376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620300376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:14:47Z","timestamp":1758366887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395620300376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":27,"alternative-id":["S0022395620300376"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.03.020","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Registered clinical trials investigating ketamine for psychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}